We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Expression of MMP-2, MMP-9, and Urokinase-Type Plasminogen Activator in Cervical Intraepithelial Neoplasia.
- Authors
No, Jae Hong; Jo, Hoenil; Kim, Su‐Hyeong; Park, In‐Ae; Kang, Daehee; Lee, Chae Hyeong; Han, Seung‐Su; Kim, Jae Weon; Park, Noh‐Hyun; Kang, Soon‐Beom; Song, Yong‐Sang
- Abstract
Matrix metalloproteinase-2 (MMP-2), MMP-9, and urokinase-type plasminogen activator (uPA) are important factors for cancer invasion and metastasis, degrading the extracellular matrix. They are also associated with angiogenesis. Angiogenic phenotype is another feature of high-grade cervical intraepithelial neoplasia (CIN). However, their associations with the progression of low-grade CIN to high-grade CIN are unexplored. We investigated whether these proteolytic enzyme expressions correlate with the progression of CIN. A total of 39 paraffin-embedded specimens from 10 patients with CIN grade 1, nine with CIN grade 2, and 20 with CIN grade 3 were assessed immunohistochemically by specific antibodies against MMP-2, MMP-9, and uPA. MMP-9 expression was higher in CIN 3 lesions (47.4%) than in CIN 1 (22.2%) and CIN 2 (20.2%) lesions, although the difference failed to reach statistical significance. The expression level of uPA and MMP-2 was not associated with the grade of CIN lesions. Interestingly, we found a significant association between expressions of uPA and MMP-2 ( P= 0.028). Our results suggest that MMP-9 might play a role in the progression of CIN.
- Subjects
UROKINASE; CANCER patients; NEOVASCULARIZATION; PLASMINOGEN; BLOOD-vessel development
- Publication
Annals of the New York Academy of Sciences, 2009, Vol 1171, p100
- ISSN
0077-8923
- Publication type
Article
- DOI
10.1111/j.1749-6632.2009.04898.x